A Dedicated Oligonucleotide Analysis System

Get information on your synthetic Oligos & Aptamers

  • Molecular weight and purity of synthetic oligos and aptamers
  • Quality control after synthesis or purification
  • Choice of short and long gradient methods
  • Ion pair mobile phases provided

Synthetic Oligonucleotide Therapies | Agilent

For workflow related questions, please contact Richard Blankley (Agilent) or Kamil Skirlo (ICL)